Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | CCR1 | P32246 | 3/20 | 0.42 |
| ▸ | CCR5 | P51681 | 3/20 | 0.42 |
| ▸ | CCR8 | P51685 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5108872 | 0.90 | RAB9A (0.39) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL30109153 | 0.82 | CYP2A6 (0.46) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL16484524 | 0.82 | CYP2A6 (0.46) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL5115970 | 0.82 | CYP2A6 (0.46) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL12150676 | 0.82 | TLR4 (0.38) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL24269007 | 0.81 | TRPV1 (0.39) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL28432843 | 0.81 | GRM5 (0.43) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL13231354 | 0.81 | RAB9A (0.38) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL5102763 | 0.81 | CYP2A6 (0.44) | SMN1; SMN2KDM4ELMNATP53CCR1 | |
| SCHEMBL5115890 | 0.80 | MEN1 (0.59) | SMN1; SMN2KDM4ELMNATP53CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1683804-B1 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-1683804-B1 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | TAKASAGO PERFUMERY CO LTD (JP) | 2013-07-31 | — | — | EP | disclosed |
| CN-100445294-C | Platinum complex and luminescent element | TAKASAGO PERFUMERY CO LTD (JP) | 2008-12-24 | — | — | CN | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-7442797-B2 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070103060-A1 | Platinum complex and light emitting device | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1683804-A2 | PLATINUM COMPLEX AND LUMINESCENT ELEMENT | Takasago International Corporation (JP) | 2006-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070103060-A1 | Platinum complex and light emitting device | UBE2D3, PCID2, CCND2 | SMN1; SMN2 2759/4885KDM4E 3127/4885LMNA 3397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.